Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Bioage Labs Inc (BIOA)

Bioage Labs Inc (BIOA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 661,055
  • Shares Outstanding, K 35,849
  • Annual Sales, $ 14,940 K
  • Annual Income, $ -98,150 K
  • EBIT $ 0 M
  • EBITDA $ 0 M
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings $-6.70 on 11/07/24
  • Next Earnings Date 05/08/18
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.89
  • Number of Estimates 2
  • High Estimate -0.88
  • Low Estimate -0.90
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.09%

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.00 +6.33%
on 11/18/24
25.33 -24.44%
on 10/28/24
-4.61 (-19.41%)
since 10/22/24

Most Recent Stories

More News
BioAge Labs to Participate in Upcoming Investor Conferences in December 2024

BioAge Labs will present at two investor conferences in December 2024, focusing on aging-related metabolic disease therapies.Quiver AI SummaryBioAge Labs, a clinical-stage biopharmaceutical company focused...

BIOA : 19.14 (+3.80%)
BioAge Labs to Present at Upcoming Investor Conferences

BIOA : 19.14 (+3.80%)
BioAge Labs Reports Third Quarter 2024 Financial Results and Provides Business Updates

BIOA : 19.14 (+3.80%)
BioAge Labs to Present Preclinical Data for APJ Agonist Azelaprag at ObesityWeek 2024

BIOA : 19.14 (+3.80%)
BioAge Labs to Present at Jefferies London Healthcare Conference

BIOA : 19.14 (+3.80%)
Prediction: These 2 Stocks Could Soar in 2025

The key word here is "could."

BIOA : 19.14 (+3.80%)
RXRX : 5.70 (-0.87%)
GLP-1 Stocks Aren't the Only Way to Benefit From the Weight Loss Drugs Boom

The future of the weight loss market might not revolve around GLP-1 drugs.

BIOA : 19.14 (+3.80%)
LLY : 748.01 (-0.25%)
ZLDPF : 102.7500 (+3.45%)
Interested in Weight Loss Stocks Besides Novo Nordisk and Eli Lilly? You Might Want To Check Out This New IPO Stock

BioAge Labs is the latest pharmaceutical company looking to make waves in the weight loss realm.

BIOA : 19.14 (+3.80%)
LLY : 748.01 (-0.25%)
Three Biotech Startups Plan $400 Million U.S. IPOs Amid Sector Resurgence

Three healthcare startups are aiming to raise up to $400 million through their U.S. initial public offerings, highlighting a strong resurgence in the biotech sector after a two-year downturn. September...

BIOA : 19.14 (+3.80%)
BCAX : 18.09 (+1.80%)
2 Next-Gen Weight Loss Stocks That Are Worth Buying Right Now

One of these businesses is a risky play, but the other is very likely to succeed.

BIOA : 19.14 (+3.80%)
LLY : 748.01 (-0.25%)

Business Summary

BioAge Labs Inc. is a clinical-stage biopharmaceutical company. It involved in developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of aging. BioAge Labs Inc. is based in RICHMOND, Calif.

See More

Key Turning Points

3rd Resistance Point 20.04
2nd Resistance Point 19.69
1st Resistance Point 19.41
Last Price 19.14
1st Support Level 18.78
2nd Support Level 18.43
3rd Support Level 18.15

See More

52-Week High 26.62
Fibonacci 61.8% 23.33
Fibonacci 50% 22.31
Fibonacci 38.2% 21.29
Last Price 19.14
52-Week Low 18.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar